1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Glomerulonephritis Global Clinical Trials Review, H2, 2015

Glomerulonephritis Global Clinical Trials Review, H2, 2015

  • September 2015
  • -
  • Global Data
  • -
  • 78 pages

Glomerulonephritis Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Glomerulonephritis Global Clinical Trials Review, H2, 2015" provides an overview of Glomerulonephritis clinical trials scenario. This report provides top line data relating to the clinical trials on Glomerulonephritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Glomerulonephritis Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Glomerulonephritis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Glomerulonephritis to Genito Urinary System And Sex Hormones Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Glomerulonephritis to Genito Urinary System And Sex Hormones Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Glomerulonephritis 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Glomerulonephritis Therapeutics Clinical Trials 31
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
F. Hoffmann-La Roche Ltd. 33
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 33
Regulus Therapeutics Inc. 34
Clinical Trial Overview of Regulus Therapeutics Inc. 34
Novartis AG 35
Clinical Trial Overview of Novartis AG 35
GlaxoSmithKline Plc 36
Clinical Trial Overview of GlaxoSmithKline Plc 36
Celldex Therapeutics, Inc. 37
Clinical Trial Overview of Celldex Therapeutics, Inc. 37
Anthera Pharmaceuticals‚ Inc. 38
Clinical Trial Overview of Anthera Pharmaceuticals‚ Inc. 38
Alexion Pharmaceuticals, Inc. 39
Clinical Trial Overview of Alexion Pharmaceuticals, Inc. 39
Bristol-Myers Squibb Company 40
Clinical Trial Overview of Bristol-Myers Squibb Company 40
Amgen Inc. 41
Clinical Trial Overview of Amgen Inc. 41
Alfa Wassermann S.p.A 42
Clinical Trial Overview of Alfa Wassermann S.p.A 42
Clinical Trial Overview of Top Institutes / Government 43
The National Institute of Diabetes and Digestive and Kidney Diseases 43
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 43
Chinese University of Hong Kong 44
Clinical Trial Overview of Chinese University of Hong Kong 44
Columbia University 45
Clinical Trial Overview of Columbia University 45
Hospital Authority 46
Clinical Trial Overview of Hospital Authority 46
Mayo Clinic 47
Clinical Trial Overview of Mayo Clinic 47
Ministry of Health, Labour and Welfare, Japan 48
Clinical Trial Overview of Ministry of Health, Labour and Welfare, Japan 48
National Institute of Arthritis and Musculoskeletal and Skin Diseases 49
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 49
National Taiwan University Hospital 50
Clinical Trial Overview of National Taiwan University Hospital 50
Radboud University 51
Clinical Trial Overview of Radboud University 51
University of Washington 52
Clinical Trial Overview of University of Washington 52
Five Key Clinical Profiles 53
Appendix 75
Abbreviations 75
Definitions 75
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 78

List of Tables
Glomerulonephritis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Glomerulonephritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Glomerulonephritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Glomerulonephritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Glomerulonephritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Glomerulonephritis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Glomerulonephritis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Glomerulonephritis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Glomerulonephritis to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Glomerulonephritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Glomerulonephritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Glomerulonephritis to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Glomerulonephritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Glomerulonephritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Glomerulonephritis Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Glomerulonephritis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Glomerulonephritis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Glomerulonephritis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Glomerulonephritis Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Glomerulonephritis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Glomerulonephritis Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Glomerulonephritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Glomerulonephritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
Glomerulonephritis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Glomerulonephritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Glomerulonephritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 33
Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Regulus Therapeutics Inc., 2015* 34
Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 35
Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 36
Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Celldex Therapeutics, Inc., 2015* 37
Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Anthera Pharmaceuticals‚ Inc., 2015* 38
Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexion Pharmaceuticals, Inc., 2015* 39
Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 40
Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015* 41
Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alfa Wassermann S.p.A, 2015* 42
Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 43
Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015* 44
Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2015* 45
Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Authority, 2015* 46
Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 47
Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Health, Labour and Welfare, Japan, 2015* 48
Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2015* 49
Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2015* 50
Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2015* 51
Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2015* 52

List of Figures
Glomerulonephritis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Glomerulonephritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Glomerulonephritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Glomerulonephritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Glomerulonephritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Glomerulonephritis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Glomerulonephritis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Glomerulonephritis to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Glomerulonephritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Glomerulonephritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Glomerulonephritis to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Glomerulonephritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Glomerulonephritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Glomerulonephritis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Glomerulonephritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Glomerulonephritis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Glomerulonephritis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Glomerulonephritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Glomerulonephritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29
Glomerulonephritis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Glomerulonephritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Glomerulonephritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 76

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.